Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Health»Invicta Diagnostic Limited Commences Commercial Operations at Dadar Centre
    Health

    Invicta Diagnostic Limited Commences Commercial Operations at Dadar Centre

    WebDeskBy WebDeskFebruary 3, 2026No Comments2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], February 03: Invicta Diagnostic Limited (NSE – INVICTA), One of the leading diagnostic service providers in Maharashtra’s healthcare services sector, announced that its Dadar Centre has commenced commercial operations on 30 January 2026. The centre marks an important step in expanding the Company’s diagnostic service portfolio and strengthening its presence in Maharashtra with a wider suite of advanced and routine modalities, including PET-CT scan, CT scan, Sonography (SONO), Pathology, and X-Ray.

    The Dadar Centre is located in the immediate vicinity of Tata Memorial Hospital, approximately 500 metres away, positioning it within a high-demand oncology diagnostics catchment area. This proximity enables faster access for patients who would otherwise face PET-CT waiting period of multiple days at large tertiary care institutions.

    The project cost is approximately ₹550 lakhs, which includes the cost of equipment, installation, and allied expenses. The commencement of services at the Dadar Centre is expected to enhance patient access to timely diagnostics, support clinicians with faster reporting, and reinforce the Company’s strategy of building capacity in high-need healthcare clusters.

    Commenting on the development, Mr. Sanket Vinod Jain, Chairman and Non-Executive Director of Invicta Diagnostic Limited, said, “The commencement of commercial operations at the Dadar Centre aligns with our strategy of expanding diagnostic capacity and adding advanced imaging modalities in key urban healthcare markets. The centre strengthens our service portfolio with PET-CT and CT, alongside routine diagnostics, and supports our focus on improving access to quality diagnostic services.

    The Dadar Centre’s location enables us to cater to a high volume of diagnostic demand, particularly for time-sensitive imaging requirements. We expect the centre to support steady utilisation, operational efficiency, and deeper engagement with clinicians and patients as we continue to build our presence across Maharashtra.”

    If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    WebDesk
    • Website

    Related Posts

    AtHomeCare™ Trials Integrated App to Streamline Post-Discharge Care, Reduce Readmissions

    October 30, 2026

    How India’s Pet Industry Can Be Enhanced with Digital Infrastructure for Information, Intelligence and Trade

    October 29, 2026

    Fredna Vet Diagnostics Uncovers Widespread Bone Tumour in Dog Through Advanced CT Imaging

    October 28, 2026

    Comments are closed.

    Recent Post
    • Eastern India’s Next Leg Of Growth Will Be Built On District Roads
    • Thyrocare Technologies revenue reaches INR 270.8 Cr in Q2 FY27, grows 25.1% YoY
    • One Analyst, 71,000 Investors: What Made Ankit Jaiswal Build NiveshX
    • SoftTech Engineers introduces CivitTDRx, a Digital-First Approach to Transparent TDR Transactions
    • Lincoln Pharmaceuticals Reports Rs. 57.50 crore Net Profit in H1 FY27, growth of 20.52 percent Y-o-Y
    • AtHomeCare™ Trials Integrated App to Streamline Post-Discharge Care, Reduce Readmissions
    • INSIGHT – The Mind Clinic, Pune Brings Nihilent’s Emoscape™ Emotion AI Platform into Clinical Practice
    • How Mobile-First Accounting Is Powering India’s Next Wave of MSME Growth

    Type above and press Enter to search. Press Esc to cancel.